2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.

Annals of the Rheumatic Diseases
Martin AringerSindhu R Johnson

Abstract

To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). This international initiative had four phases. (1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta-regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort and a patient survey. (2) Criteria reduction by Delphi and nominal group technique exercises. (3) Criteria definition and weighting based on criterion performance and on results of a multi-criteria decision analysis. (4) Refinement of weights and threshold scores in a new derivation cohort of 1001 subjects and validation compared with previous criteria in a new validation cohort of 1270 subjects. The 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in seven clinical (constitutional, haematological, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and three immunological (antiphospholipid antibodies, complement proteins, SLE-specific antibodies) doma...Continue Reading

References

Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
May 1, 1995·Baillière's Clinical Rheumatology·D T Felson, J J Anderson
Jun 2, 2006·Arthritis and Rheumatism·Jasvinder A SinghUNKNOWN Classification and Response Criteria Subcommittee of the Committee on Quality Measures, American College of Rheumatology
Apr 4, 2007·Annals of Internal Medicine·Matthew M HsiehGriffin P Rodgers
Oct 2, 2007·Arthritis and Rheumatism·Maxime Dougados, Laure Gossec
Oct 2, 2007·Arthritis and Rheumatism·Sindhu R JohnsonDaniel H Solomon
Feb 29, 2008·The New England Journal of Medicine·Anisur Rahman, David A Isenberg
Mar 23, 2011·Seminars in Arthritis and Rheumatism·Raj NairDinesh Khanna
Dec 2, 2011·The New England Journal of Medicine·George C Tsokos
Jul 11, 2013·Nature Reviews. Rheumatology·George K BertsiasDimitrios T Boumpas
Apr 12, 2014·Journal of Clinical Epidemiology·Sindhu R JohnsonDinesh Khanna
Oct 11, 2014·Arthritis Care & Research·Karen H Costenbader, Peter H Schur
Mar 18, 2015·Arthritis Care & Research·Rohit AggarwalBrian M Feldman
May 26, 2017·Arthritis Care & Research·Nicolai LeuchtenUNKNOWN Systemic Lupus Erythematosus Classification Criteria Steering Committee
Dec 30, 2017·Arthritis Care & Research·Gabriela SchmajukUNKNOWN SLE classification criteria steering committee and the international SLE expert panel of the initiative
May 18, 2018·Lupus·N LeuchtenUNKNOWN ; on behalf of the SLE Classification Criteria Steering Committee
Jan 30, 2019·Annals of the Rheumatic Diseases·Sara K TedeschiKaren H Costenbader
Feb 12, 2019·Journal of Proteome Research·Frida TorellJohan Trygg
Sep 29, 2019·Arthritis Care & Research·Zahi ToumaUNKNOWN ACR/EULAR group, New SLE classification criteria for clinical research are being developed, sponsored by EULAR, ACR

❮ Previous
Next ❯

Citations

Jan 21, 2020·RMD Open·Guillermo J Pons-EstelUNKNOWN Grupo Latino Americano De Estudio de Lupus (GLADEL)
Mar 11, 2020·Lupus Science & Medicine·Ioannis ParodisFrédéric A Houssiau
May 28, 2020·Zeitschrift für Rheumatologie·T Rose, T Dörner
Jun 10, 2020·ESC Heart Failure·Liang LiuYingping Tian
Apr 12, 2020·Clinical Rheumatology·Arash Mollaeian, Christopher Haas
Jun 12, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F MitriM Kraemer
Jul 22, 2020·The Journal of International Medical Research·Katarina Mlekuš KozamernikMarija Pfeifer
Jul 8, 2020·Deutsche medizinische Wochenschrift·Johanna Mucke, Matthias Schneider
Aug 19, 2020·Chinese Medical Journal·Yong FanZhuo-Li Zhang
Aug 5, 2020·Expert Review of Clinical Immunology·Wenhui ZhouQianjin Lu
Jan 25, 2020·Nature Reviews. Disease Primers·Hans-Joachim AndersChandra Mohan
Nov 7, 2019·Nutrients·Chiara PellicanoEdoardo Rosato
Nov 23, 2019·International Journal of Molecular Sciences·Gian Marco GhiggeriMaurizio Bruschi
Mar 11, 2020·Clinical Rheumatology·Maria Colon, Lara El Khoury
May 15, 2020·Current Rheumatology Reports·Martin AringerSindhu R Johnson
Mar 30, 2020·Zeitschrift für Rheumatologie·H-M LorenzF Lorenz
May 28, 2020·Immunological Medicine·Yuichiro Fujieda
Jul 24, 2020·Annals of the Rheumatic Diseases·Duncan PorterStefan Siebert
Jul 9, 2020·Diagnostic Cytopathology·Aparna NingombamAnita Chopra
Apr 25, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Qiu-Xia ZhangLi Yang
Jun 13, 2020·International Journal of Molecular Sciences·Paul R J AmesFabrizio Gentile
Jun 6, 2020·Current Rheumatology Reports·Myrto KostopoulouGeorge Bertsias
Jun 4, 2020·Rheumatology and Therapy·Fabio BastaAndreas Schwarting
Jun 26, 2020·Rheumatology Advances in Practice·Felix BongominMark Kaddumukasa
Apr 6, 2020·Current Allergy and Asthma Reports·Amy J PettyMatilda W Nicholas
Jun 10, 2020·International Journal of Hematology·Satoshi IchikawaHideo Harigae
Sep 26, 2020·Frontiers in Immunology·Cecilia Beatrice ChighizolaFrancesco Tedesco
May 12, 2020·Lupus·José A González-RegueiroRicardo U Macías-Rodríguez
Feb 1, 2020·Arthritis Care & Research·Marvin J FritzlerYvan St Pierre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.